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Members of the Ca2+/calmodulin-dependent protein kinase II (CaMK-II) family are encoded throughout the animal kingdom by up to four
genes (a, h, g, and y). Over three dozen known CaMK-II splice variants assemble into ¨12-subunit oligomers with catalytic domains facing out
from a central core. In this study, the catalytic domain of a, h, and y CaMK-IIs was replaced with cyan (CFP) or yellow fluorescent protein (YFP)
for fluorescence resonance energy transfer (FRET) studies. FRET, when normalized to total CFP and YFP, reproducibly yielded values which
reflected oligomerization preference, inter-subunit spacing, and localization. FRET occurred when individual CFP and YFP-linked CaMK-IIs
were co-expressed, but not when they were expressed separately and then mixed. All hetero-oligomers exhibited FRET values that were averages
of their homo-oligomeric parents, indicating no oligomeric preference or restriction. FRET for CaMK-II homo-oligomers was inversely
proportional to the variable region length. FPs were monomerized (Leu221 to Lys221) for this study, thus eliminating any potential artifact caused
by FP-CaMK-II aggregates. Our results indicate that a, h, and y CaMK-IIs can freely hetero-oligomerize and that increased variable region
lengths place amino termini further apart, potentially influencing the rate of inter-subunit autophosphorylation.
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CaMK-II (Ca2+/calmodulin(CaM)-dependent protein kinase
II) is a highly conserved serine/threonine protein kinase
encoded by 4 genes (a, h, g, and y) to produce at least 38
alternative splice variants [1,2], some of which are targeted to
the cytoskeleton, membrane, or nucleus [3–5]. Like other
kinases, CaMK-II location specifies function [6–9]. CaMK-IIs
form uniquely shaped oligomers of approximately 12 subunits
[10–13]. Oligomerization is necessary for the Ca2+/CaM-
induced inter-subunit autophosphorylation, which renders the
enzyme Ca2+-independent and thus active long after the initial
Ca2+ pulse has subsided [2,14,15].
CaMK-II is expressed in all tissues in species as diverse as sea
sponge and humans [1]. Although a and h are the most common
CaMK-IIs in the central nervous system, and g and y CaMK-IIs
are the most common in embryonic cells [16–24], most cells or
tissues transcribe from two or more CaMK-II genes [16,25–28].
Hetero-oligomers exist naturally [29], raising the possibility of a0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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E-mail address: rmtombes@vcu.edu (R.M. Tombes).dizzying potential array of mixed oligomers, each with its own
potentially unique targeting or substrate specificity. For exam-
ple,a andhCaMK-IIs are known to formmixed oligomers [29–
32] and aKAP, a naturally truncated a CaMK-II, can hetero-
oligomerize with h, g, and y CaMK-IIs [33]. However,
quantitative assessments of the ability of one CaMK-II to
hetero-oligomerize with another have been lacking.
The C-terminal oligomerization or association domain is
sufficient for oligomer formation [30,34]. Throughout this
¨132 amino acid domain (excluding the y-specific C-terminal
tail), there are 39 residue differences amongst all four human
CaMK-IIs [1], raising the possibility that these sequences may
confer an oligomeric preference, even if slight.
CaMK-II oligomers are formed by a core of oligomerization
(O) domains linked to outwardly-facing N-terminal catalytic
(C) domains via the variable (V) domain [10–12]. The 29 to
218 amino acid V domain is encoded by the alternative use of
up to eight exons per CaMK-II gene. Variable domain exons
encode targeting, not just linker sequences [1], but the roles of
all alternative exons are not yet known. In purified CaMK-II
holoenzymes, the inter-subunit spacing of C domains, as
determined by electron microscopy, is ¨7 nm [10,11].ta 1746 (2005) 45 – 54
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fluorescent proteins, CFP (cyan) and YFP (yellow), has been
used to demonstrate the interaction of proteins to which they are
linked [35]. If two proteins stably interact, fluorescent excitation
of CFP (donor) at 440 nm excites YFP (acceptor) at 480 nm to
fluoresce at 535 nm. Such studies can be conducted on FP-linked
proteins in living cells or in lysates. The Fo¨rster critical distance
for CFP/YFP FRET pairs (50% efficiency) is 5 nm [36], making
FRET possible if the 27 kDa CFP or YFP is placed at the N-
terminus of CaMK-II. GFP has been successfully linked in this
fashion to CaMK-II, as evaluated by normal location, oligo-
merization and Ca2+/CaM-dependent activity [4,37].
There was therefore precedent and reason to use CFP/YFP
FRET to systematically examine a, h, and y CaMK-IIs for their
propensity to oligomerize with each other and themselves. g
CaMK-II was omitted from this study, since as shown in Fig. 1,
it is nearly identical to h CaMK-II in the oligomerization
domain [1]. Most constructs used in this study were prepared by
replacing the C domain with CFP or YFP. CFP and YFP
naturally but weakly dimerize; they were monomerized to
eliminate artifactual aggregation of FP-linked CaMK-IIs. We
limited our study to four cytosolic a, h, and y CaMK-II variants
chosen based on their comparable V domain structure [1]. NIH/
3T3 cells were used since CaMK-II expression levels are low,
minimizing complication by excess endogenous CaMK-II. ThisFig. 1. CaMK-II Domain Structure. All CaMK-IIs examined in this study consisted o
domains (VO, shaded), except for one full length (CVO) h construct and one OT con
tested are shown starting at residue 310 (a) or 311 (h and y), where FPs end and V
shown with gene-specific residues underlined. Mouse and human O domain sequestudy demonstrates that CaMK-II assembly and structure can be
quantitatively evaluated using CFP/YFP FRET.
2. Materials and methods
2.1. CFP and YFP vector construction
Sequences encoding Cyan Fluorescent Protein (CFP) or Yellow Fluorescent
Protein (YFP) were linked to the 5V end of mouse or human CaMK-II cDNAs
using the BamH1 and BspE1 restriction sites in the ECFP-C1 and EYFP-C1
vectors (Clontech Inc., Palo Alto CA), as previously described [37]. This limits
the linker sequence between G/C/YFP and CaMK-II to 1 glycine residue.
Variable domain constructs begin with Thr311 (h, y) or Thr310 (a) and the y
CaMK-II oligomerization domain construct begins with Thr351 to encode the
last 142 amino acids, as previously described [37]. Monomerization of GFP,
CFP and YFP by point mutagenesis (Leu221 to Lys221) was accomplished using
Pfu Turbo DNA polymerase (Stratagene, La Jolla, CA) with a complementary
mutagenic primer pair [38]. The sense sequence for this primer pair was 5V-
GATCACATGGTCCTTAAGGAGTTCGTGACC-3V. The reaction product was
digested with DpnI for 30 min and then transformed into E. coli. Positive
clones were screened for an introduced AflII restriction site and then sequenced
through the FP and CaMK-II coding sequences, as previously described [16].
Once expressed, all mCFP and mYFP-linked CaMK-IIs were evaluated by GFP
immunoblots and Superose-12 gel filtration, as described below.
2.2. Transfection and preparation of lysates
CFP/YFP pairs were transfected into subconfluent NIH/3T3 cells using
Lipofectamine 2000 (Invitrogen Inc., Carlsbad CA). After 1 to 2 days, cellsf CFP or YFP linked at the amino terminus of the variable and oligomerization
struct, containing the alternative y-specific tail. Sequences of the mouse variants
domains begin and continue without any gaps through the O domain, which are
nces are identical for all four genes.
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buffer, briefly sonicated on ice and then centrifuged at 12,000g for 15 min, as
previously described [37]. These supernatants were used for all subsequent
FRET and immunoblot analyses. This homogenization buffer was previously
optimized for solubilizing and maintaining maximum CaMK-II activity and
consists of 30 mM HEPES, pH 7.4, 2.6 mM EGTA, 20 mM MgCl2, 80 mM h-
glycerol phosphate, 0.1 AM okadaic acid, 0.01 mg/ml each chymostatin,
leupeptin, aprotinin, pepstatin, and soybean trypsin inhibitor (Sigma Chemical
Co., St. Louis MO).
2.3. FRET fluorometry
Lysates were assayed for CFP (donor) fluorescence (445ex/480em), YFP
(acceptor) fluorescence (485ex/535em) and FRET (445ex/535em) using a Wallac
(Perkin Elmer) Victor2 Multilabel 96-well counter as previously described [39].
Each 0.1–0.2 ml sample was counted in replicate for 2 s each. After background
(untransfected cells) subtraction, corrected FRET was calculated by subtracting
CFP (17%) and YFP (3%) bleedthrough from raw FRET. Bleedthrough is the
percentage of total CFP or YFP fluorescence detected in the FRETchannel when
CFP or YFP are transfected separately and is instrumentation-specific. Corrected
FRET was then normalized by dividing by the square root of the product of the
intensities of both fluorophores, as described [36], leaving a unitless value:
NFRET=100 [FRET (0.17*CFP) (0.03YFP)] / (CFPYFP)2.
2.4. FRET microscopy
For conventional microscopy, cells were imaged on an Olympus IX70
inverted epifluorescent microscope with a 40 dry objective. The Endow
EGFP filter utilized a 470/40 nm excitation filter and a 525/40 nm emission
filter with a 495 nm long pass dichroic filter (Chroma Technology, Rockingham
VT) and was used for all 3 FPs. For FRET, filters were 440/21 nm excitation
and 535/26 nm emission with a 455 nm long pass dichroic. Confocal images
were acquired using an LSM-510 microscope (Carl Zeiss Inc., Thornwood,
NY) equipped with a Plan Apochromat 63 oil immersion objective (1.4
N.A.). Excitation was provided by a 30-mW argon laser. Excitation was tuned
to 458 nm for CFP and 514 for YFP. Emission was set to 470–500 for CFP and
530–600 for the YFP and FRET channels using dichroic and band pass filters.
Images were obtained sequentially in the CFP and YFP channels and then
processed using the FRET versionC macro, which subtracts bleedthrough from
each channel and computes NFRET, as described [36]. Displayed images were
acquired and then scaled using identical parameters within each channel for all
samples.
2.5. Immunoblotting
5 Ag protein of sonicated lysates from transfected cells per lane was
separated on 7.5% polyacrylamide gels using the Mini-Protean II gel
electrophoresis system (Bio-Rad). Proteins were transferred to 0.45 Am
nitrocellulose for 1 h at 100 V and blocked with Tris-buffered saline with
0.1% Tween-20 (TBST), 5% BSA, and 2% normal goat serum for 1 h. The
primary antibody was a mouse anti-GFP IgG (Clontech Inc.), which reacts
equally well with CFP, YFP, and GFP. It was diluted to 1 Ag/ml in 2% BSA/
TBST and incubated overnight with the nitrocellulose. Blots were washed three
times with TBST and incubated for 1 h with alkaline phosphatase-conjugated
goat anti-mouse IgG at 2 Ag/ml in 2% BSA/TBST. Blots were washed three
times with TBSTand developed with 0.25 mg/ml each nitro blue tetrazolium and
5-bromo-4-chloro-3-indolyl phosphate in 0.1 M NaCl, 5 mM MgCl2, pH 9.4.
2.6. Immunoprecipitation
100 Ag of sonicated lysate protein from cells transfected with GFP-linked
h and/or y CaMK-II was incubated with either 1 Ag of mouse anti-h CaMK-II
(Zymed Laboratories, San Francisco CA) or goat anti-y CaMK-II (Santa Cruz
Biotechnology, Santa Cruz CA) overnight at 4 -C. This was immunopreci-
pitated with either biotinylated goat anti-mouse or biotinylated donkey anti-
goat IgG (Kierkegaard Perry Labs, Gaithersburg MD) respectively, followed
by streptavidin-magnespheres (Promega, Madison WI). Samples were washedthree times with 0.5 ml TBST, resuspended in SDS sample buffer and
processed for immunoblotting, as described above. Samples were probed with
1 Ag/ml rabbit anti-GFP IgG (Clontech Inc.) and alkaline phosphatase
conjugated goat anti-rabbit IgG at 2 Ag/ml in 2% BSA/TBST as described
above.
2.7. Native molecular weight determinations
CFP and YFP-linked CaMK-IIs were co-expressed, from which whole cell
lysates were prepared. Approximately 150 Ag of lysate was loaded onto a 1.0
cm40 cm Superose-12 gel filtration column (Amersham Pharmacia Biotech,
Piscataway, NJ) in 50 mM Tris, pH 7.4, 150 mM NaCl, 5% glycerol, and 0.001
mg/ml each chymostatin, leupeptin, aprotinin, pepstatin, and soybean trypsin
inhibitor. Superose-12 has a reported exclusion limit of 2106 Da. Fractions
were assessed for CFP and YFP fluorescence, which was then integrated and
plotted as a function of Kav. Kav was determined from the elution volume (Ve),
void volume (V0) and total volume (VT): Kav= (VeV0) / (VeV0), as
previously described [37]. Standards included thyroglobulin (Mr 669 kDa),
apoferritin (Mr 443 kDa), catalase (Mr 232 kDa), aldolase (Mr 158 kDa), and
bovine serum albumin (Mr 66 kDa). Peak retention times of each standard was
determined from in-line absorbance at 280 nm.
3. Results
3.1. CaMK-II constructs
For this study, the 315-amino acid catalytic domain (C) was
replaced by CFP or YFP (238 amino acids) to encode an FP
followed by variable (V) and oligomerization (O) domains
(Fig. 1). In addition to VO constructs, one full length FP-linked
construct was evaluated (CVO) as were VOT and OT
constructs, which contain the y CaMK-II specific alternative
C-terminal tail (Fig. 1). The four FP-linked CaMK-II variants
examined here included a, he, yA (also known as y1), and yC
(also known as y2). a and yC are comparable as they utilize no
alternative variable domains, whereas yA and he are both
encoded by two gene-specific variable domain exons [1]. GFP
linked at the amino terminus of VO CaMK-II exhibits native
oligomeric size and location [7,37]. Since oligomerization is
dependent on the O domain, its sequence in all four (a, h, g,
and y) CaMK-IIs is listed with gene-specific residues under-
lined (Fig. 1). There were 21 gene-specific residues in a, 14 in
y, 5 in h, and 4 in g. Because g has the least unique sequence
(Fig. 1) and most identity to h [1], it was not included in this
study.
3.2. Use of monomeric fluorescent proteins
In order to evaluate CaMK-II assembly, the tendency of FP-
linked CaMK-IIs to form aggregates was addressed. Although
the reported diameter of a CaMK-II dodecamer is ¨20 nm [10]
and naturally occurring CaMK-II aggregates of 100 nm have
been reported in anoxic brain [40], overexpressed FP-linked
CaMK-IIs form fluorescent aggregates up to 10 Am in diameter
(Fig. 2). These intracellular fluorescent aggregates accumulated
over time; small aggregates could be seen coalescing into larger
ones during an imaging session. Aggregates were dependent on
CaMK-II oligomerization and could be minimized if imaging
occurred within the first 24 h [37]. Aggregates are demon-
strated here with he VO CaMK-II linked to CFP, GFP and YFP,
Fig. 2. Monomerized GFP, CFP and YFP CaMK-IIs Do Not Aggregate. NIH/3T3 cells were transfected separately with original or ‘‘monomerized’’ GFP, CFP or YFP-
linked to heVO and imaged live after 24 h for 0.5 s each. Monomerized FPs were created through a point mutation, which converts Leu
221 to Lys221. Scale bar=50 Am.
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highest proportion of aggregates and CFP-CaMK-II had the
least. Although CaMK-II oligomerization is absolutely re-
quired for aggregate formation, CaMK-II sequence variations
had no detectable effect on the degree of aggregate formation.
Large aggregates were easily visible by phase contrast
microscopy (Fig. 2 inset). Based on the dimensions of
CaMK-II [10], these aggregates could contain as many as
109 CaMK-II dodecamers.
GFP is known to dimerize [41] and the residues Ala206,
Leu221, and Phe223 are known to be responsible for this weak
(Kd=0.11 mM) self-interaction [42]. Mutation of any of these
residues (e.g., Leu221 to Lys221) disrupts this hydrophobic
patch, thus yielding monomeric FPs [38]. Since the CaMK-II
oligomerization domain is found at the C-terminus and the FP
is at the N-terminus, we postulated that these aggregates
reflected multiple weak FP dimerization domains juxtaposedby CaMKII oligomerization [10]. When FPs were monomer-
ized by converting Leu221 to Lys221, aggregates were elimi-
nated (Fig. 2). The cells shown here were imaged live exactly
24 h after transfection. All subsequent experiments utilized
monomeric FPs (mFPs).
3.3. CaMKII oligomerization can be quantitatively evaluated
by FRET
Each FRET analysis was conducted by co-transfecting
equivalent masses of CFP and YFP bearing vectors into
NIH/3T3 cells. Cleared cell lysates were measured in the CFP
(donor), YFP (acceptor), and FRET channels. Bleedthrough
(17% for CFP and 3% for YFP) was the average percentage of
total CFP or YFP fluorescence detected in the FRET channel
when CFP or YFP was transfected separately and was used in
all subsequent calculations to obtain a corrected FRET value,
Fig. 3. NFRET depends on donor/acceptor ratios. NFRET values from three
separate experiments in which the ratio of CFP-linked a VO CaMK-II and
YFP-linked a VO CaMK-II was intentionally varied are plotted as a function of
the logarithm of the CFP/YFP (donor/acceptor) ratio. A polynomial equation
curve fit was used.
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present to yield NFRET (see Materials and methods).
As an example, FRET of a VO CaMK-II is shown (Table
1). Although quantum yields of CFP and YFP differ [43], CFP
signals were similar to YFP signals when equivalent amounts
of CFP and YFP-encoding vectors were transfected (rows 1, 8,
and 11). NFRET was near zero when CFP and YFP alone were
co-transfected (row 1), when either YFP or CFP was co-
transfected with CFP-a CaMK-II or YFP-a CaMK-II, respec-
tively (rows 4 and 5), or when CFP-a CaMK-II and YFP-a
CaMK-II were transfected separately and then mixed (row 11).
In contrast, when CFP-a CaMK-II and YFP-a CaMK-II were
co-transfected, NFRET values were above 20.
When the ratio of CFP-a CaMK-II and YFP-a CaMK-II was
intentionally varied (Table 1, rows 6–10), NFRET values
peaked at D/A near 1 (log D/A=0; Fig. 3). Curve fitting
suggests relative stability of the NFRET signal within approx-
imately 3-fold in either direction away from a D/A of 1. Beyond
those ratios, NFRET decreased, as expected. We selected an
arbitrary filter for all subsequent analyses to exclude the few
samples in which the D/A ratio was less than 0.5 or greater than
2.0. The average D/A ratio was 0.98T0.44 (S.D.) when
averaged for all subsequent samples in which equivalent CFP
and YFP vector masses were transfected.
3.4. Verification of construct integrity, relative mass,
oligomerization and native size
Representative co-expressed CFP or YFP-linked constructs
exhibited similar mass at the expected Mr, without degradation,
when immunoblotted with an anti-FP antibody (Fig. 4A),
demonstrating that all CaMK-IIs studied here had similar
expression efficiency and stability.
The hetero-oligomerization of CaMK-IIs was also directly
demonstrated using immunoblotting (Fig. 4B). CFP-linked h
CVO CaMK-II and YFP-linked yA VOT CaMK-II were
expressed separately (lanes 2 and 3, respectively) or together
(lanes 1 and 4) and then immunoprecipitated with anti-hTable 1
Demonstration of FRET approach
Samples Donor Acc
1. CFP and YFP 716,363 1,18
2. YFP-CaMKII alone 12,378 97
3. CFP-CaMKII alone 1,164,784 1
4. CFP-CaMKII and YFP 245,783 1,22
5. CFP and YFP-CaMKII 924,394 37
6. *CFP-CaMKII and YFP-CaMKII 52,622 94
7. *CFP-CaMKII and YFP-CaMKII 153,321 86
8. *CFP-CaMKII and YFP-CaMKII 358,839 55
9. *CFP-CaMKII and YFP-CaMKII 656,618 29
10. *CFP-CaMKII and YFP-CaMKII 896,035 13
11. CFP-CaMKII and YFP-CaMKII
expressed separately then mixed
604,004 52
Fluorometry values (donor: 445ex/480em, acceptor: 485ex/535em and FRET: 445ex/5
acceptor ratios and calculatedNFRET. Unless indicated (*), equivalentmasses of CFP
were prepared and 2-s fluorometry measurements taken. Constructs used here inclu
CaMK-II in the combinations indicated. CFP/YFP vector mass ratios were intentiona
DNA.CaMK-II (lanes 1 and 2) or anti-y CaMK-II (lanes 3 and 4). yA
VOT CaMK-II was used because the anti-y CaMK-II antibody
reacts with the T domain. Samples were then probed with anti-
FP to reveal both CaMK-IIs co-associating when reciprocally
immunoprecipitated (lanes 1 and 4). This approach has
previously demonstrated CaMK-II hetero-oligomerization
[29], but cannot as easily be normalized or quantitated as
NFRET and cannot distinguish co-migrating subunits.
The native sizes of all CFP-and YFP-linked CaMK-IIs were
evaluated by Superose-12 gel filtration chromatography (Fig. 5).
Shown here are a, he, and yC VO CaMK-IIs, each of which
exhibited single peak fluorescence corresponding to ¨700
kDa, as did all other constructs examined. The predicted size of
FP-linked VO CaMK-II dodecamers is between 540 and 660
kDa. There is no indication that FP-linked CaMK-IIs partially
or inefficiently oligomerize. Unlinked CFP or YFP alone
migrated at 30 kDa. CFP and YFP a VO CaMK-IIs, whicheptor FRET D/A ratio NFRET
4,471 172,190 0.60 1.62
7,436 35,785 0.01 3.96
5,199 201,846 76.64 2.54
9,592 89,336 0.20 1.94
1,475 174,240 2.49 1.02
0,385 72,276 0.06 15.79
9,009 127,436 0.18 20.63
3,762 183,376 0.65 23.72
2,717 209,428 2.24 20.31
4,239 205,336 6.67 14.12
7,154 135,192 1.15 2.96
35em) after background subtraction (untransfected cells) are shown with donor/
andYFP-based constructs were transfected into NIH/3T3 cells. After 24 h, lysates
ded CFP alone, YFP alone, CFP-linked a VO CaMK-II and YFP-linked a VO
lly varied in rows 6–10 (*) while maintaining a constant total amount of vector
Fig. 4. Immunoblot Analysis of Transfected lysates. (A) Lysates transfected with similar levels of CFP and YFP-linked constructs, as confirmed by fluorescence
readings, were separated by SDS-PAGE and probed with an anti-FP antibody. Samples shown here represent most of the constructs utilized in this study. (1) CFP-
heVO with YFP-aVO; (2) CFP-heVO with YFP-yAVOT; (3) CFP-yAVOTwith YFP-yAVOT; (4) CFP-yAVOTwith YFP-yCVO; (5) CFP-yCVO with YFP-heVO; (6)
CFP-yCVO with YFP-yAVOT; (7) CFP-yAVOTwith YFP-yOT; (8) CFP-hCVO with YFP-hCVO. (B) Lysates were transfected with CFP-hCVO (lanes 1, 2 and 4) or
YFP-yAVOT (lanes 1, 3 and 4) and then immunoprecipitated with anti-h CaMK-II (lanes 1 and 2) or anti-y CaMK-II (lanes 3 and 4). Immunoprecipitated samples
were then probed with anti-GFP.
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mers, even though they do not FRET.
3.5. CaMK-IIs freely hetero-oligomerize
NFRET values were averaged from 5 to 12 separate
transfections for each condition and included reciprocal pairs
for hetero-oligomers (Fig. 6). Only samples that (a) exceeded
10-fold over background and (b) exhibited D/A ratios between
0.5 and 2.0, as described above, were included. NFRET values
for homo-oligomers (Fig. 6, solid bars) ranged from 8.3 (h
CVO) to 24.4 (y OT). As confirmed by immunoblot, h CVO
encoded the largest FP-linked CaMK-II and y OT the smallest.
NFRET values for a, h, and y mixed oligomers ranged from
12.2 to 20.3. All samples were significantly higher than
unlinked CFP and YFP, as determined by t-test (P=0.01).
Such robust NFRET values for hetero-oligomers do not
support preferential homo-oligomer formation, since the
resultant CFP or YFP-only homo-oligomers would not FRETFig. 5. FP-CaMK-IIs Efficiently Oligomerize. Superose-12 gel filtration
column chromatography and fluorescent analysis of fractions of a, he, and
yC CFP and YFP-linked VO CaMK-II homo-oligomers. Alpha mix represents
CFP and YFP-linked a VO CaMK-II expressed separately and then mixed prior
to chromatography. Fractions were assessed for CFP and YFP fluorescence,
which was integrated and then plotted as a function of Kav. Standards displayed
included thyroglobulin (Mr 669 kDa), apoferritin (Mr 443 kDa), and aldolase
(Mr 158 kDa).(Table 1). If subtle oligomerization preferences existed,
NFRET values of hetero-oligomers should differ significantly
from their parental homo-oligomers (Table 2). NFRET in all 6
possible VO hetero-oligomeric pairs was not significantly
different (t-test) from the NFRET average of their homo-
oligomeric parents (Table 2).
3.6. NFRET is influenced by variable domains, not gene of
origin
The inferred proportionality of NFRET to CaMK-II size was
examined more closely by plotting NFRET for homo-oligo-
mers versus variable domain length (Fig. 7). The variable
domain for this study spans from Thr311 in h/y or Thr310 in a to
a common residue (Arg346 in yC CaMK-II) at the beginning of
the oligomerization domain (RKQEI, Fig. 1). NFRET values
for he VO, yA VO, and yA VOT, which have 69-75 residue
variable domains, were all low (11.9, 11.7 and 11.9). yA VOT
and yA VO had indistinguishable NFRET, demonstrating that
the T domain had no influence on NFRET. NFRET for a and
yC VO, which have 35–36 residue variable domains, was
higher (21.6 and 19.7). NFRET for y OT, which is composed of
only 8 linker residues, exhibited the highest NFRET (24.4).
These 6 constructs all exhibited NFRET that was inversely
proportional to their variable domain length (Fig. 7).
3.7. FRET microscopy
With conventional fluorescence microscopy, CaMK-II
FRET intensity levels varied in parallel to fluorometry values,
but neither the spectral separation nor quantitative capability
matched that of confocal microscopy. For confocal microscopy,
cells were transfected with combinations of CFP or YFP linked
to a, he, or yC VO constructs. Cells were then fixed after 24
h and imaged (Fig. 8). Spectral separation was excellent as
bleedthrough was minimal in the samples transfected with CFP
and YFP alone (images not shown). FRET and NFRET were
low in cells transfected with unlinked CFP and YFP and high
with CaMK-IIs. a CaMK-II was more uniformly distributed
within the cytoplasm than h and y, which were cytoskeletal and
perinuclear, as previously described [4,37]. The perinuclear
pattern of y and the actin fiber pattern of h were dominant over
Fig. 6. FRET Fluorometry. One CFP and one YFP-linked construct were co-expressed in NIH/3T3 cells. NFRET values were determined in lysates prepared from 1-
to 2-day transfectants. Homo-oligomers are graphed in solid bars and hetero-oligomers in striped bars. Unless otherwise indicated, all constructs were VO. Each bar
represents 3–8 replicate and separate transfections including reciprocal pairs and are plotted as means with standard deviations. ‘‘a MIX’’ was a-CFP and a-YFP
expressed separately and then mixed.
K. Lantsman, R.M. Tombes / Biochimica et Biophysica Acta 1746 (2005) 45–54 51a in hetero-oligomers. h CaMK-II also exhibited focal
adhesion-like intensities. In general, for these constructs and
all other combinations tested, FRET localization matched the
pattern in each separate channel. NFRET values across all cells
varied in the same range (10–25; green to yellow) as the
NFRET range determined in solution, but revealed no new
targeting of CaMK-II hetero-oligomers.
4. Discussion
This study has demonstrated that fluorescence resonance
energy transfer (FRET) can be used to quantitatively character-
ize the assembly and structure of oligomeric CaMK-II in
solution and in cells. Although previous studies have demon-
strated that CaMK-IIs can form hetero-oligomers when co-
expressed [30,33], this is the first report that has demonstratedTable 2
Predicted NFRET is Not Significantly Different from Actual NFRET for
Hetero-oligomers
PAIR n NFRET (S.D.) Predicted NFRET P
yA and he 8 12.19 (1.02) 11.80 0.45
yC and he 6 15.50 (0.71) 15.84 0.43
yC and yA 5 15.95 (1.05) 15.69 0.73
a and he 5 15.87 (0.56) 16.75 0.07
a and yA 5 16.07 (0.80) 16.62 0.32
a and yC 7 20.33 (1.14) 20.66 0.60
Determined NFRET values for VO hetero-oligomers are listed with standard
deviations (SD) and are compared to the predicted average of the NFRET
values of the parental homo-oligomers. Two-tailed t-test P values are listed for
each comparison and indicate no significant difference between predicted and
measured NFRET.that FRETcan be used to evaluate the propensity of CaMK-IIs to
hetero-oligomerize. Our findings have also demonstrated that
CaMK-II variable domains influence amino terminal spacing.
We have found that all co-expressed CaMK-IIs freely hetero-
oligomerize. In contrast, when unlinked (C or Y)FP was co-
transfected with (Y or C)FP-linked CaMK-II, FRET was not
observed. This demonstrated that FRET was dependent on
CaMK-II interaction, not FP interaction. It also demonstrated
that homo-oligomers bearing a single fluorophore do not exhibit
FRET. As importantly, FP-linked CaMK-IIs that were expressed
separately and then mixed at high concentrations also lackedFig. 7. NFRET Depends on Linker Distance. NFRET values of homo-
oligomers were plotted as a function of number of amino acids in the V
(variable) domain.
Fig. 8. FRET Confocal Imaging. Selected VO constructs were transfected into NIH 3T3 cells, fixed 24 h after transfection and then imaged in the following channels:
donor-CFP (column 1), acceptor-YFP (column 2) and FRET (column 3). NFRET (column 4) across the image was calculated from the first three channels as
indicated in the methods. Shown are a, he, and yC homo-oligomers or hetero-oligomers as indicated. Scale bar=50 Am. NFRET color lookup bar values range from
black (0) to red (30).
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values for hetero-oligomers was indistinguishable from the
average of their homo-oligomeric parents, indicating no
oligomeric preference. If CaMK-II assembly had favored the
formation of homo-oligomers, then NFRET levels would have
decreased in co-expression studies relative to the average of the
parents. It has been suggested that when two different CaMK-IIs
are co-expressed, the resulting oligomers are composed of a
mixture of homo-oligomers and hetero-oligomers [29]. Al-
though a small percentage of homo-oligomers would form byrandom chance (<1%), our findings indicate that there is no
significant formation of homo-oligomers in co-expression
studies. The natural existence of CaMK-II homo-oligomers
[29] must therefore be the result of expression of a single CaMK-
II gene product at one time or place.
NFRET levels increased as CaMK-II variable domain length
decreased, regardless of gene of origin. Since all CaMK-IIs
tested here freely hetero-oligomerize, this can be interpreted as
the result of either decreasing the distance between donor and
acceptor, removing restrictions on their interaction imposed by
K. Lantsman, R.M. Tombes / Biochimica et Biophysica Acta 1746 (2005) 45–54 53variable domain secondary structure or optimizing their relative
angle for FRET. Since catalytic domains are the amino terminal
domains of full length CaMK-IIs, our findings can be
extrapolated to reflect an effect on the ability of native
CaMK-IIs to undergo inter-subunit autophosphorylation in
CaMK-IIs bearing shorter variable domains. Previous studies
have shown that recombinant purified a and h CaMK-II homo-
oligomers differ in their ability to bind CaM and autopho-
sphorylate [11,29]. Integrated with our findings, the observed
differences in autophosphorylation [29] could therefore be due
to inter-subunit restriction caused by variable domain
sequences. Such a dependence of autophosphorylation rates
on linker length is exactly what was recently suggested in a
study of h CaMK-II isoforms [44]. This may have develop-
mental significance to CaMK-II Ca2+ sensitivity in general
since h, g, and y CaMK-II variants with longer variable
domains replace shorter ones as organisms proceed through
development [1]. Interestingly, in spite of their structural
similarity, a is expressed only in the postnatal central nervous
system and yC is exclusively embryonic. The y-specific C-
terminal tail had no effect on FRET, oligomeric size, or
localization; its role remains unknown.
Subunit spacing can be estimated from the FRET efficiency
in each experiment and from R0, the Fo¨rster critical distance.
R0 is 5 nm for CFP/YFP pairs [36]. Efficiency values can be
determined from the corrected FRET signal and the donor
fluorescence in the presence of acceptor [45] and for our
experiments, varied from 8 to 37% depending on the pair tested
and the ratio of donor to acceptor. At donor (CFP) to acceptor
(YFP) ratios near unity, R ranged from 5.5 (a–y hetero-
oligomers or a–a homo-oligomers) to 7.5 nm (full length h
homo-oligomers). This is consistent with the inter-subunit
distance of ¨7 nm as determined from electron microscopy for
full length CaMK-II [11] and supports a role for variable
domain length in inter-subunit spacing. Although we sought
samples in which the molar ratios of CFP and YFP-linked
CaMK-IIs were near unity, the dependence of NFRET on donor
and acceptor ratios provides some insight into the oligomeric
structure. Even in samples where the molar ratio, as determined
by immunoblot, was closer to 10 than 1, the NFRET signal was
still 50% of maximum. This suggests that regardless of the
oligomeric model [10–13], amino terminal domains of all
individual subunits must be near the minimum FRET distance
(¨10 nm) within the oligomer. Even with full length h CVO,
where amino terminal domains would be even farther from
each other, NFRET was still significantly above background,
although about one third of the y OT homo-oligomer.
We conducted confocal NFRET imaging to test whether any
hetero-oligomeric combinations exhibited new targeting
domains created by the juxtaposition of adjacent, but different
monomers. Quantitative spatial analysis of FRET can define
any such unique localization of hetero-oligomers, but must be
normalized to account for uneven distribution of fluorophores.
Using confocal microscopy, we were able to localize CFP/YFP
CaMK-II hetero-oligomers and obtained NFRET values
throughout the cell that were in the same range as the values
obtained in cell lysates. Although individual fluorophore-linked CaMK-IIs localized as expected and h and y localization
dominated over a, hetero-oligomers exhibited no dramatically
different or unique localization. NFRET did reveal some subtle
variations throughout the cell; whether hetero-oligomers have
altered substrate or binding partner specificity is a topic of
current study.
FRET localization required that we eliminate fluorescent
aggregates. These aggregates were an artifact of FPs but were
dependent on CaMK-II oligomerization. In our constructs, the
FP and CaMK-II binding domains are at each end of the
resulting chimeric proteins. In the known CaMK-II oligomeric
structure, multiple amino termini (FPs) are placed extending
outward from a central core [10–13]. A single point mutation
in the FP-dimerization domain (Leu221 to Lys221) dramatically
overcame this artifact in all FPs without altering their
fluorescent properties, as previously described [38]. Any study
using FP-linked to any oligomeric protein (particularly if the
FP is at the opposite face from the oligomerization domain) is,
in principal, susceptible to this artifact.
In conclusion, we have not only demonstrated the practi-
cality of CFP/YFP FRET in evaluating dynamic CaMK-II
assembly and structure, but have shown that a, h, and y
CaMK-IIs freely hetero-oligomerize, when co-expressed, in
spite of up to 21 unique amino acid residues (out of a total of
132 residues) per gene in the oligomerization domain. We have
also shown that FRET can be used to localize hetero-oligomers
in cells. Our findings indicate that the influence of variable
domains on the CaMK-II holoenzyme is not always through
specific targeting motifs, but through the introduction of
variable domain spacers, which can alter the relative position
of catalytic domains, potentially influencing Ca2+ sensitivity.
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